Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma

Clinical trial NCT03614364 · UNKNOWN

Trial details

NCT number: NCT03614364
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Salivary Duct Carcinoma

Start date: 2018-09-20
Primary completion: 2022-09-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.